We have spoken with the families of people who died following ingestion of the defective Digitek pills, and who suffered symptoms consistent with digoxin toxicity before they passed away. We are now reviewing possible lawsuits.
Get information on potential lawsuits related to Digitek double-strength tablets.
A Class I recall was issued by Actavis Totowa LLC on April 25, 2008 for all lots of the heart medicine Digitek (generic name digoxin) because some have been found to contain twice the approved levels of active ingredient than is appropriate.
Unfortunately, this recall comes too late for the families whose loved ones
ingested the potentially deadly dose.
According to the Food and Drug
Administration, several reports of illnesses and injuries have been
received.
Digitek is used to treat heart failure and abnormal heart
rhythms. The existence of double strength tablets poses a risk of digoxin
toxicity in patients with renal failure.
Digoxin toxicity can cause
nausea, vomiting, dizziness, low blood pressure, cardiac instability and
bradycardia. Death can also result from excessive intake of digoxin.
A
growing number of families are coming forward to say the death of a loved one
was caused by defective Digitek tablets. If you have been harmed by Digitek,
please complete the form below for a free legal review of your potential case. A
representative of our firm will be in touch shortly.
see also:
Digoxin Recall
Drug Maker Issues Recall of Digoxin (Brand Name Digitek)--LawyersDigoxin recall sparks potential lawsuits--Get a free case review
Digitek Recall
FDA: Digitek Recall Due to Some Double Doses--Free Lawsuit ReviewSearching for lawsuit information on Digitek recall? Digitek Lawyers
Digitek
Lawyers Respond to Recall of Double-Strength Digitek TabletsLawyers review potential cases of overdosed Digitek--Free lawsuit Info


